- Home
- TERN vs SDHY Comparison
TERN vs SDHY Comparison
Compare TERN & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- SDHY
- Stock Information
- Founded
- TERN 2017
- SDHY 2020
- Country
- TERN United States
- SDHY United States
- Employees
- TERN N/A
- SDHY N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- SDHY Finance/Investors Services
- Sector
- TERN Health Care
- SDHY Finance
- Exchange
- TERN Nasdaq
- SDHY Nasdaq
- Market Cap
- TERN 499.4M
- SDHY 405.6M
- IPO Year
- TERN 2021
- SDHY N/A
- Fundamental
- Price
- TERN $6.80
- SDHY $16.26
- Analyst Decision
- TERN Buy
- SDHY
- Analyst Count
- TERN 5
- SDHY 0
- Target Price
- TERN $18.30
- SDHY N/A
- AVG Volume (30 Days)
- TERN 1.8M
- SDHY 94.0K
- Earning Date
- TERN 11-12-2024
- SDHY 01-01-0001
- Dividend Yield
- TERN N/A
- SDHY 8.46%
- EPS Growth
- TERN N/A
- SDHY N/A
- EPS
- TERN N/A
- SDHY 1.07
- Revenue
- TERN N/A
- SDHY N/A
- Revenue This Year
- TERN N/A
- SDHY N/A
- Revenue Next Year
- TERN N/A
- SDHY N/A
- P/E Ratio
- TERN N/A
- SDHY $14.31
- Revenue Growth
- TERN N/A
- SDHY N/A
- 52 Week Low
- TERN $4.32
- SDHY $13.93
- 52 Week High
- TERN $11.40
- SDHY $15.50
- Technical
- Relative Strength Index (RSI)
- TERN 52.65
- SDHY 32.63
- Support Level
- TERN $6.41
- SDHY $16.43
- Resistance Level
- TERN $7.14
- SDHY $16.60
- Average True Range (ATR)
- TERN 0.48
- SDHY 0.12
- MACD
- TERN 0.10
- SDHY -0.03
- Stochastic Oscillator
- TERN 59.76
- SDHY 2.17
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.